Michael J. Fox Foundation

The Michael J. Fox Foundation has issued a grant to support MapLight’s pursuit of novel therapeutic targets for Parkinson’s disease patients experiencing anxiety and depression related to neurodegeneration.


Why Partner with Maplight?

MapLight is founded on the discovery and development of transformative therapeutics for patients with significant unmet needs. Partnerships and collaborations are a valuable avenue to bring diverse insights from multiple organizations to collectively further our mission.

To partner with MapLight, please provide a non-confidential overview of the opportunity including your objectives.

info@maplightrx.com 

Your interest is appreciated. We look forward to considering all opportunities.